Maxeye Successfully Resolved Patent Litigation with Wacom
Press Release

Maxeye Successfully Resolved Patent Litigation with Wacom

Comprehensive Settlement and Licensing Agreement Reached SHENZHEN, China, Sept. 7, 2026 /PRNewswire/ — Maxeye announced today that it has successfully resolved its patent litigation with Wacom in the U.S. District Court for the Eastern District of Texas. The lawsuit, which involved seven Wacom patents regarding stylus pens, has culminated in a comprehensive settlement. The case […]

Read More
People See One Brand. The Internet May Show Them Hundreds More.
Press Release

People See One Brand. The Internet May Show Them Hundreds More.

The gap between what organisations control and what people trust may be larger than many realise. SINGAPORE, Sept. 7, 2026 /PRNewswire/ — Every day, consumers decide whether to trust a website, email, link or digital service. What they rarely see is where an organisation’s official digital presence ends and similar-looking identities begin. For most people, […]

Read More
Baidu Announces Inclusion of Its Class A Ordinary Shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect Programs
Press Release

Baidu Announces Inclusion of Its Class A Ordinary Shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect Programs

BEIJING, Sept. 7, 2026 /PRNewswire/ — Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that the Company’s Class A ordinary shares traded on The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") have been […]

Read More
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
Press Release

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

Interim MASTRR Registry analysis represents, to Aroa’s knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand, Sept. 7, 2026 /PRNewswire/ — Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced the peer-reviewed publication of interim results from its ongoing MASTRR Registry, reporting low infection rates and […]

Read More
Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims
Press Release

Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims

CEO Ji-yong Yoon presents proprietary liposome validation framework: "Scientific validation should come before a product is labeled ‘liposomal.’" As Korea’s pioneer in commercializing liposomal health functional foods, Wooree Group aims to set new industry quality standards. Showcases an integrated bio value chain spanning raw ingredients, manufacturing, and consumer brands at Vitafoods Asia. SEOUL, South Korea […]

Read More
CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients
Press Release

CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients

– First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients– Highlighted CART blood pressure monitor’s multifaceted value, including ESH-based validation and sleep apnea tracking MUNICH and SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ — Sky Labs (CEO Jack ByungHwan Lee) announced on the 3rd that it shared clinical research outcomes […]

Read More
Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
Press Release

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

— Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection — — Robust neutralizing antibody responses across RSV, hMPV and PIV3 in Phase 2 recapitulates Phase 1 results demonstrating best-in-class breadth (with no […]

Read More
Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion
Press Release

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 7, 2026 /PRNewswire/ — Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion. The shares so repurchased will be cancelled or held as treasury shares. Taking concrete […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.